Symbols

RADX

Radiopharm·NASDAQ

--(--)

Market Open: --

--(--)

Pre-Market: --

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About RADX

Radiopharm Theranostics Limited

A clinical stage radiotherapy company

Industry

Pharmaceutical

Established Date

Listing Date

11/27/2024

Exchange

NASDAQ Stock Exchange

Full-time Employees

Fiscal Year Ends

06-30

Website

www.radiopharmtheranostics.com

Security Type

Depository Receipts (Ordinary Shares)

Office address

Level 3, 62 Lygon Street, Carlton VIC 3053, Australia

Business

Clinical Stage Radiation Therapy Company

Introduction

Radiopharm Theranostics Limited was incorporated under the laws of Australia in February 2021. The Company is a research and development company that develops and commercializes radiopharmaceutical product platforms for precision oncology therapeutic and diagnostic applications. The targeted and scientifically validated radiopharmaceutical technology they developed is in preclinical and clinical development. These techniques cover molecules of all sizes, including peptides, small molecules, and antibodies attached to medical-quality radioisotopes. They are seeking registration and marketing approval for each of their products and therapies under development in the US, EU, UK, China, Japan, Australia and Canada.